title: First case of A859T epidermal growth factor receptor mutation responding to erlotinib.
authors.affiliation: Pulmonology Department, Academic Hospital, Angers, France.
authors.forename: Laureline
authors.initials: L
authors.lastname: Le Maignan
authors.forename: Delphine
authors.initials: D
authors.lastname: Mirebeau-Prunier
authors.forename: Laurent
authors.initials: L
authors.lastname: Vervueren
authors.forename: Thierry
authors.initials: T
authors.lastname: Jeanfaivre
authors.forename: Thierry
authors.initials: T
authors.lastname: Urban
authors.forename: José
authors.initials: J
authors.lastname: Hureaux
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D004273:DNA, Neoplasm / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics*; D000069347:Erlotinib Hydrochloride; D005091:Exons / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D016133:Polymerase Chain Reaction; D049268:Positron-Emission Tomography; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011799:Quinazolines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D004273:DNA, Neoplasm; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors